Maxima Biotech Annual Review and Future Outlook Briefing.
- 其偉 朱
- Dec 17, 2024
- 1 min read
Maxima Biotech focuses on high-end minimally invasive medical devices and has successfully completed a market cycle for its wireless ultrasonic scalpel in Taiwan. This wireless ultrasonic scalpel enhances the safety and efficiency of minimally invasive surgeries and has achieved a market share of approximately 7-8% in Taiwan.
Looking ahead, Maxima plans to implement the "Category Champion" strategy to enter international markets. Additionally, the company is actively pursuing a "Little Helper" strategy to establish connections with international industry leaders, leveraging Taiwan's strengths in efficient innovation and cost-effective mass production to further expand the influence of Taiwan's medical device industry in the global market.
For further information, you may refer to https://www.facebook.com/events/3857606187840966/?rdid=zR0sBpPkXaLZMT0J&share_url=https%3A%2F%2Fwww.facebook.com%2Fshare%2F3xB3iCQ368UrdDB6%2F#

留言